Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel
LON:4BB

4basebio Final Earnings Report

4basebio logo
GBX 550 +20.00 (+3.77%)
As of 11:50 AM Eastern
ProfileEarnings HistoryForecast

4basebio EPS Results

Actual EPS
-GBX 0.94
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

4basebio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

4basebio Announcement Details

Quarter
Final
Date
5/27/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

4basebio Earnings Headlines

4basebio CEO Increases Stake with Market Purchase of Ordinary Shares
May 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/4basebio-ceo-increases-stake-with-market-purchase-of-ordinary-shares?utm_source=marketbeat.com&utm_medium=referral
4basebio PLC
May 22, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/4bb/financials?countrycode=uk
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
June 1 at 1:00 AM  |  Profits Run (Ad)
4basebio Plc - 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial
May 20, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-4basebio-signs-clinical-060000075.html
Final Results and Notice of AGM
May 20, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/final-results-and-notice-of-agm-1036178747
4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial
May 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/4basebio-signs-clinical-supply-agreement-110000880.html
See More 4basebio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 4basebio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 4basebio and other key companies, straight to your email.

About 4basebio

4basebio (LON:4BB) is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

View 4basebio Profile
Earnings Tools